A C3aR antagonist, SB290157 was shown to attenuate albuminuria and improve renal fibrosis in a rat model of T2D, as well as to inhibit inflammatory and fibrotic markers in human renal glomerular endothelial cells cultured in high-glucose conditions (85, 87). This evidence concerns the gene C3AR1 and type 2 diabetes mellitus.